Alentis Therapeutics AG

History from 29 Mar 2019

UID: CHE-227.760.145
Legal form: AG
Canton: BL
Founded: 29 Mar 2019
Amount raised: not in the SHAB
Lead investor: not in the SHAB

Nominal capital · CHFCHF 5.6M

shares
Vorzugsaktien A-1
Vorzugsaktien A-0
Vorzugaktien A-1
Vorzugsaktien B
Vorzugsaktien C
Vorzugsaktien D

Show 12 earlier entries

SHAB published 3 Apr 2019 · legal date 29 Mar 2019
Company formed
Founded 29 Mar 2019
SHAB HR01-1004602067 ↗
SHAB published 23 Apr 2019 · legal date 12 Apr 2019
Capital increase
Not assessed
Paid in cash
Nominal capital
109’604 → 250’519.06
Shares
996’400 → 2’277’446
New shares, % of post-step shares
56.2% (1’281’046 new)
Share classes
996’400 × CHF 0.11 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1
SHAB HR02-1004614843 ↗
SHAB published 11 Feb 2021 · legal date 3 Feb 2021
Capital increase
Not assessed
Paid in cash
Nominal capital
250’519.06 → 261’915.06
Shares
2’277’446 → 2’381’046
New shares, % of post-step shares
4.4% (103’600 new)
Share classes
996’400 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1
SHAB HR02-1005098130 ↗
SHAB published 25 Mar 2021 · legal date 11 Mar 2021
Capital increase
Not assessed
Paid in cash
Nominal capital
261’915.06 → 291’844.74
Shares
2’381’046 → 2’653’134
New shares, % of post-step shares
10.3% (272’088 new)
Share classes
1’268’488 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1
SHAB HR02-1005133231 ↗
SHAB published 6 Apr 2021 · legal date 24 Mar 2021
Capital increase
Not assessed
Paid by converting claims
Nominal capital
291’844.74 → 513’690.65
Shares
2’653’134 → 4’669’915
New shares, % of post-step shares
43.2% (2’016’781 new)
Share classes
1’268’488 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugaktien A-1 · 2’016’781 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005141003 ↗
SHAB published 25 Jun 2021 · legal date 15 Jun 2021
Capital increase
Not assessed
Paid in cash
Nominal capital
513’690.65 → 580’983.59
Shares
4’669’915 → 5’281’669
New shares, % of post-step shares
11.6% (611’754 new)
Share classes
1’268’488 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 2’628’535 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005228553 ↗
SHAB published 7 Feb 2022 · legal date 19 Jan 2022
Capital increase
Not assessed
Paid in cash
Nominal capital
580’983.59 → 646’184.33
Shares
5’281’669 → 5’874’403
New shares, % of post-step shares
10.1% (592’734 new)
Share classes
1’861’222 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 2’628’535 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005398927 ↗
SHAB published 25 Mar 2022 · legal date 14 Mar 2022
Capital increase
Not assessed
Paid in cash
Nominal capital
646’184.33 → 778’126.58
Shares
5’874’403 → 7’073’878
New shares, % of post-step shares
17.0% (1’199’475 new)
Share classes
1’861’222 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 3’828’010 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005435706 ↗
SHAB published 13 May 2022 · legal date 28 Apr 2022
Capital increase
Not assessed
Paid in cash
Nominal capital
778’126.58 → 789’950.26
Shares
7’073’878 → 7’181’366
New shares, % of post-step shares
1.5% (107’488 new)
Share classes
1’968’710 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 3’828’010 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005473182 ↗
SHAB published 13 Feb 2023 · legal date 3 Feb 2023
Capital increase
Not assessed
Paid in cash
Nominal capital
789’950.26 → 938’045.24
Shares
7’181’366 → 8’527’684
New shares, % of post-step shares
15.8% (1’346’318 new)
Share classes
2’137’184 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’005’854 × CHF 0.11 Vorzugsaktien B
SHAB HR02-1005676632 ↗
SHAB published 11 May 2023 · legal date 5 Apr 2023
Capital increase
Not assessed
Paid in cash
Nominal capital
938’045.24 → 1’196’749.07
Shares
8’527’684 → 10’879’537
New shares, % of post-step shares
21.6% (2’351’853 new)
Share classes
2’137’184 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 1’435’752 × CHF 0.11 Vorzugsaktien C
SHAB HR02-1005744007 ↗
SHAB published 11 May 2023 · legal date 5 Apr 2023
Capital band adopted
SHAB HR02-1005744007 ↗

SHAB published 25 Oct 2023 · legal date 22 Sep 2023
Capital increase
Not assessed
Paid in cash
Nominal capital
1’196’749.07 → 1’426’469.11
Shares
10’879’537 → 12’967’901
New shares, % of post-step shares
16.1% (2’088’364 new)
Share classes
2’137’184 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 3’524’116 × CHF 0.11 Vorzugsaktien C
SHAB HR02-1005868703 ↗
SHAB published 24 Nov 2023 · legal date 2 Nov 2023
Capital increase
Not assessed
Paid in cash
Nominal capital
1’426’469.11 → 1’587’780.81
Shares
12’967’901 → 14’434’371
New shares, % of post-step shares
10.2% (1’466’470 new)
Share classes
3’603’654 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 3’524’116 × CHF 0.11 Vorzugsaktien C
SHAB HR02-1005893298 ↗
SHAB published 21 Mar 2024 · legal date 29 Feb 2024
Capital increase
Not assessed
Paid in cash
Nominal capital
1’587’780.81 → 1’817’500.52
Shares
14’434’371 → 16’522’732
New shares, % of post-step shares
12.6% (2’088’361 new)
Share classes
3’603’654 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C
SHAB HR02-1005991413 ↗
SHAB published 21 Mar 2024 · legal date 29 Feb 2024
Capital band adopted
SHAB HR02-1005991413 ↗
SHAB published 1 May 2024 · legal date 12 Apr 2024
Capital increase
Not assessed
Paid in cash
Nominal capital
1’817’500.52 → 1’838’291.73
Shares
16’522’732 → 16’711’743
New shares, % of post-step shares
1.1% (189’011 new)
Share classes
3’792’665 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C
SHAB HR02-1006022553 ↗
SHAB published 23 Oct 2024 · legal date 3 Oct 2024
Capital band changed
SHAB HR02-1006160996 ↗
SHAB published 22 Nov 2024 · legal date 11 Nov 2024
Capital increase
Not assessed
Paid in cash and by other means
Nominal capital
1’838’291.73 → 4’496’597.49
Shares
16’711’743 → 40’878’159
New shares, % of post-step shares
59.1% (24’166’416 new)
Share classes
3’792’665 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C · 24’166’416 × CHF 0.11 Vorzugsaktien D
SHAB HR02-1006185663 ↗
SHAB published 22 Nov 2024 · legal date 11 Nov 2024
Capital band changed
SHAB HR02-1006185663 ↗
SHAB published 19 Jun 2025 · legal date 23 May 2025
Capital increase
Not assessed
Paid in cash
Nominal capital
4’496’597.49 → 4’759’320.50
Shares
40’878’159 → 43’266’550
New shares, % of post-step shares
5.5% (2’388’391 new)
Share classes
6’181’056 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C · 24’166’416 × CHF 0.11 Vorzugsaktien D
SHAB HR02-1006360776 ↗
SHAB published 10 Sep 2025 · legal date 25 Aug 2025
Capital increase
Likely financing
Paid in cash
Nominal capital
4’759’320.50 → 4’916’350.23
Shares
43’266’550 → 44’694’093
New shares, % of post-step shares
3.2% (1’427’543 new)
Share classes
7’608’599 × CHF 0.11 · 103’600 × CHF 0.11 Vorzugsaktien A-0 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C · 24’166’416 × CHF 0.11 Vorzugsaktien D
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.75 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006429636 ↗
SHAB published 24 Sep 2025 · legal date 26 Aug 2025
Capital increase
Likely financing
Paid in cash
Nominal capital
4’916’350.23 → 5’603’850.23
Shares
44’694’093 → 50’944’093
New shares, % of post-step shares
12.3% (6’250’000 new)
Share classes
13’962’199 × CHF 0.11 · 1’281’046 × CHF 0.11 Vorzugsaktien A-1 · 5’921’955 × CHF 0.11 Vorzugsaktien B · 5’612’477 × CHF 0.11 Vorzugsaktien C · 24’166’416 × CHF 0.11 Vorzugsaktien D
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006441014 ↗
SHAB published 24 Sep 2025 · legal date 26 Aug 2025
Capital band changed
SHAB HR02-1006441014 ↗

Published by 24 Sep 2025

Latest available record · 8 Oct 2026

Alentis Therapeutics AG

Record

Company formed

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital increase

Capital band adopted

Capital increase

Capital increase

Capital increase

Capital band adopted

Capital increase

Capital band changed

Capital increase

Capital band changed

Capital increase

Capital increase

Capital increase

Capital band changed